News

The health care community’s efforts alone are not enough to stem the tide of the opioid epidemic. We need more help from the federal government.

The AHA today expressed support for and urged all senators to support an amendment to the Labor, Health and Human Services and Education appropriations bill that would help address the out-of-control cost of prescription drugs.

The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, today joined more than a dozen other health organizations in urging the Food and Drug Administration to finalize guidance critical to increasing competition in the biologics marketplace and expanding access to more affordable biosimilar options, similar to the generic options that exist today for molecule drugs.

The Department of Health and Human Services today issued a request for information seeking input on reporting criteria for the Electronic Health Record Reporting Program required by the 21st Century Cures Act.

Nearly half of Ohio’s Medicaid expansion new enrollees reported improvement in their overall health status since enrolling in Medicaid, compared to 3.5 percent who said their health had worsened, according to a report released by the state’s Department of Medicaid.

The AHA’s Hospitals Against Violence initiative and AHA’s Health Research & Educational Trust’s Hospital Improvement Innovation Network Aug. 27 at 12 p.m. ET will host a webinar on preventing violence in the workplace.

The Centers for Medicare & Medicaid Services today in a letter to state Medicaid directors outlined its current policies related to budget neutrality for Medicaid demonstration projects authorized under Section 1115 of the Social Security Act and provided states insights into the agency’s decision-making process.

The departments of Health and Human Services and the Treasury today approved a Section 1332 waiver for Maryland to implement a five-year reinsurance program for its individual health insurance market beginning in 2019.

The Food and Drug Administration today awarded a contract to the National Academies of Sciences, Engineering, and Medicine to develop evidence-based guidelines for appropriate opioid analgesic prescribing for acute pain resulting from specific conditions or procedures.

In 2016, the difference between the amount that the Medicare drug benefit program reported spending on 29 brand-name combination medications and the estimated spending for generic constituents for the same number of doses was $925 million.

The National Human Trafficking Training and Technical Assistance Center Sept. 5 at 1 p.m. ET will host a webinar highlighting emerging trends, case studies and best practices for providing supportive services to individuals with disabilities who are at risk or currently experiencing human trafficking.

The Hospital Council of Northern and Central California has selected Bryan Bucklew as its new president and CEO. Bucklew has led the Greater Dayton Area Hospital Association in Ohio since 2005.

Hospitals, health systems and health care organizations can register today to participate as a host site for the Institute for Diversity and Health Equity’s Fall Enrichment Program.

Using and building analytic tools to improve quality of care, focusing on diversity and inclusion, and partnering with patients, families, and communities: All are part of the quality commitment at Anne Arundel Medical Center (AAMC) in Annapolis, Md., and Aurora Health Care (now Advocate Aurora Health) in Milwaukee, both finalists for the 2018 AHA Quest for Quality Prize.

The Centers for Medicare & Medicaid Services today awarded $8.6 million to 30 states and the District of Columbia to provide state insurance regulators with the opportunity to enhance states’ ability to strengthen their health insurance markets through innovative measures.

The Food and Drug Administration Aug. 17 issued a safety alert after reviewing the final results from a post-approval study conducted by SynCardia Systems for their Temporary Total Artificial Heart (TAH-t) Companion 2 Driver System.

Clinicians can apply through Sept. 6 to participate in the Centers for Medicare & Medicaid Services' Medicare Advantage Qualifying Incentive Arrangement Demonstration.

The Drug Enforcement Administration today issued its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would reduce manufacturing quotas for six frequently misused opioids by an average 10 percent.

The Centers for Medicare & Medicaid Services has approved DNV GL – Healthcare for continued recognition as a national accrediting organization for hospitals that wish to participate in the Medicare and Medicaid programs.

The departments of Health and Human Services and the Treasury yesterday approved a Section 1332 waiver for New Jersey to implement a five-year reinsurance program for its individual health insurance market beginning in 2019.